| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,854 |
2,285 |
$141K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
276 |
173 |
$14K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
284 |
223 |
$13K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
142 |
117 |
$11K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
101 |
79 |
$8K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
314 |
261 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
84 |
59 |
$7K |
| 87999 |
|
125 |
109 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
66 |
47 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
21 |
15 |
$2K |
| 96127 |
|
65 |
45 |
$949.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
56 |
50 |
$788.14 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
13 |
$529.95 |
| 90686 |
|
14 |
13 |
$102.23 |
| 94760 |
|
13 |
13 |
$57.20 |
| 1159F |
|
2,190 |
1,602 |
$0.00 |
| 1160F |
|
2,190 |
1,602 |
$0.00 |
| 99072 |
|
151 |
135 |
$0.00 |
| 3210F |
|
59 |
56 |
$0.00 |
| 3078F |
|
150 |
133 |
$0.00 |
| 1003F |
|
159 |
104 |
$0.00 |
| 3074F |
|
1,509 |
1,066 |
$0.00 |